Asosiy kontentga oʻtish
AkademScholar
Muassasalar

National Medical Research Center for Hematology

Nom variantlari: Federal State Institution Hematology Research Center · NMRC for Hematology · ГУ Гематологический научный центр РАМН · Гематологический научный центр Министерства здравоохранения РФ · ФГБУ «НМИЦ Гематологии» Минздрава России · Федеральное государственное бюджетное учреждение «Гематологический научный центр» Министерства здравоохранения и социального развития Российской Федерации · Центральный научно-исследовательский институт гематологии и переливания крови · Центральный ордена Ленина институт переливания крови

Davlat:
RU
ROR:
https://ror.org/015fskz95
2
h-indeks
6
Iqtiboslar
16
Asarlar
42
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0134501220102018201920202021202220232024202520262010: Nashrlar 1, Iqtiboslar 02018: Nashrlar 1, Iqtiboslar 02019: Nashrlar 2, Iqtiboslar 12020: Nashrlar 2, Iqtiboslar 12021: Nashrlar 1, Iqtiboslar 12022: Nashrlar 1, Iqtiboslar 02023: Nashrlar 3, Iqtiboslar 02024: Nashrlar 3, Iqtiboslar 22025: Nashrlar 0, Iqtiboslar 12026: Nashrlar 1, Iqtiboslar 0

Iqtibos tarixi

01220102018201920202021202220232024202520262010: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 12020: Iqtiboslar 12021: Iqtiboslar 12022: Iqtiboslar 02023: Iqtiboslar 02024: Iqtiboslar 22025: Iqtiboslar 12026: Iqtiboslar 0

Nashr tarixi

0134520102018201920202021202220232024202520262010: Nashrlar 12018: Nashrlar 12019: Nashrlar 22020: Nashrlar 22021: Nashrlar 12022: Nashrlar 12023: Nashrlar 32024: Nashrlar 32025: Nashrlar 02026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01220102018201920202021202220232024202520262010: h-indeks 02018: h-indeks 02019: h-indeks 12020: h-indeks 12021: h-indeks 12022: h-indeks 12023: h-indeks 12024: h-indeks 22025: h-indeks 22026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. [Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].20100 iqtibos
  2. Chronic Myeloid Leukemia Diagnosed during Pregnancy: Therapy, Outcomes and Follow-up20180 iqtibos
  3. Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database20190 iqtibos
  4. PF666 LOW JAK2 V617F ALLELE BURDEN PHI‐NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS MAY ASSOCIATE WITH ADDITIONAL CALR OR MPL MUTATIONS20190 iqtibos
  5. The frequency of detection of anti-HBc in blood donors from four regions of Russia20210 iqtibos
  6. Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry20220 iqtibos
  7. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 iqtibos
  8. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 iqtibos
  9. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 iqtibos
  10. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry20240 iqtibos